Schizandrin B attenuates hypoxia/reoxygenation injury in H9c2 cells by activating the AMPK/Nrf2 signaling pathway
Bo Zhao(Capital Medical University), Sheng Zhao(Capital Medical University), Jianjun Peng(Capital Medical University), Guangping Li(Qingdao University), Huiming Ye(Capital Medical University), Lihui Ren(Capital Medical University), Licheng Lei(Capital Medical University), Zuo-Yan Wang(Capital Medical University)
Cited by 27
Related Papers
The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy
|Nature Medicine|2016|393
Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats
|Cardiovascular Diabetology|2019|296
Association Between C-Reactive Protein and Recurrence of Atrial Fibrillation After Successful Electrical Cardioversion
|Journal of the American College of Cardiology|2007|271
The T peak − T end interval as an electrocardiographic risk marker of arrhythmic and mortality outcomes: A systematic review and meta-analysis
|Heart Rhythm|2017|192
Mouse models of atherosclerosis: a historical perspective and recent advances
|Lipids in Health and Disease|2017|167